🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our PhD student, Su Khin presenting outcomes of oral v injectable Semaglutide on behalf of #ABCD Emma Wilmot Uni of Nottingham School of Medicine #WeAreUoN ABCD Diabetes

*NEW* Progression maps of uptake of #ClosedLoop in ages 0-18 living with #T1Diabetes All 42 ICS included- variation improving The aim? A fully dark green map Onwards, amigos. There is no time for hesitation or false steps. Lets get it done (Data via National Paediatric Diabetes Audit (NPDA) ) #gbdoc

Huge congratulations Melanie on your Diabetes Care, a research journal of the ADA 🌟 award for Outstanding Achievement in Clinical Diabetes Research! Amazing! 👏👏👏🎊🎊 Pratik Choudhary Prof Kamlesh Khunti Claire Meek #ADA2025

So proud of Melanie 🌱Leicester Diabetes who received Outstanding Investigator award American Diabetes Association - DiabetesPro Prof Kamlesh Khunti

Exciting news! The 19th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2026) will be held in Barcelona, Spain on 11–14 March 2026! 📝 Abstract submissions are NOW OPEN! Submit here: invt.io/1txb9vb8em7 #ATTD2026 #DiabetesTech

Highly recommended

Huge congratulations to our Co-Director, Melanie, who is the first woman outside the USA to receive the American Diabetes Association National Scientific and Health Care Achievement Award 🏆 We're so proud of your achievement! Read more below ⬇️

Access to #ClosedLoops Post Year 1 of NHS England 5 year implementation plan NICE TA 943 aka “Artificial Pancreas” Priority group: Ages 0-18 Target to attain: 85-90% Keep at it people We change the paradigm of care in the #NHS Forever 💙 #gbdoc

Upper limb complications are 2 to 3-fold higher in diabetes but are often overlooked and may markedly impact quality of life, causing pain, mobility issues, and disability. ADA Professional Publications Read Here➡️ diabetesjournals.org/care/lookup/do…

📉 Real-World Semaglutide Use in the U.S. ❌ Many patients deviate from recommended dose-escalation ⚠️ High discontinuation rates seen in practice 🧠 Better support is needed for patients & clinicians 🔗 onlinelibrary.wiley.com/doi/full/10.10… #Obesity #GLP1 #Semaglutide #RealWorldEvidence

The median HbA1c in ages 0-18 in those with #T1Diabetes is now the best this country ergo NHS has ever achieved And the same for ages 19-25 And the same for ages 26+ That's the tweet. Wes Streeting Department of Health and Social Care #gbdoc

Why Do Patients Discontinue GLP-1 Medications for Obesity? Adherence Challenges ❌ 50% stop treatment within 6 months Top Reasons for Stopping 🤢 Side effects (mainly GI): 36% 🚗 Logistics (travel, time): 24% 💰 Cost & affordability: 23% dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…

Our study shows SARS-CoV-2 Infection associated with New-Onset T1 Diabetes in Children 📊Children exposed to COVID-19 had a 2.4 to 4.2x ⬆️ Risk was highest 1–7 months post-infection Strongest association seen during the Delta variant onlinelibrary.wiley.com/doi/10.1111/dm…

Did you know who is eligible for a 'Islet-Cell Transplant' on the background of #T1Diabetes? Have a look- it's in NICE NG17 -updated 2022 Continued Hypos -inspite of other treatments- is one. Link: nice.org.uk/guidance/ng17/… cc NHS Diabetes Programme Diabetes UK Breakthrough T1D UK

Watch this space! This could be the start of something amazing for #T1D #making plans together. Strength is working together rather than in silos BSPED PCDO Society Ketan Dhatariya T1Early

❤️ Weight & HbA1c Reductions associated with mortality & cardiovascular benefits Meta-regression of 44 trials ⚖️ Each 1 kg weight loss = 3.4% ↓ mortality risk 🩸 Each 1% HbA1c ⬇️ = 7.6% ↓ mortality risk 📉 Effects regardless of drug class dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…

🌍 Language Matters in Diabetes Tech Access US study 📊 Non-English speaking individuals less likely to receive CGM prescriptions. 🩺 Study shows language is an independent barrier. ✅Need language inclusive strategies jamanetwork.com/journals/jaman… Tadej Battelino

Our recent publication on Neural Mechanisms and Alterations of Sweet Sensing: Insights from Functional MRI Studies ⁦Uni of Nottingham School of Medicine #WeAreUoN⁩ ⁦University Hospitals of Derby and Burton NHS FT⁩ mdpi.com/2075-1729/15/7…

And yet we know that only 54% of people over the age of 75 w T1D are using CGM. Really important for NHS England and clinical bodies like the ABCD to address this gap Partha S Kar 🇮🇳🇬🇧🏏🎥 thoughts?

The 'Decision Support Tool' for those living with #T1Diabetes Published January 2024 NHS England Built with many living with #T1D and clinical colleagues in the #T1D space Do use, RT and cascade as you need to! (Also available in Bengali; Polish; Urdu & Punjabi) Breakthrough T1D UK